CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors

Neuron. 2023 Jan 4;111(1):65-80.e6. doi: 10.1016/j.neuron.2022.10.018. Epub 2022 Nov 4.

Abstract

The primary cilium is a central signaling component during embryonic development. Here we focus on CROCCP2, a hominid-specific gene duplicate from ciliary rootlet coiled coil (CROCC), also known as rootletin, that encodes the major component of the ciliary rootlet. We find that CROCCP2 is highly expressed in the human fetal brain and not in other primate species. CROCCP2 gain of function in the mouse embryonic cortex and human cortical cells and organoids results in decreased ciliogenesis and increased cortical progenitor amplification, particularly basal progenitors. CROCCP2 decreases ciliary dynamics by inhibition of the IFT20 ciliary trafficking protein, which then impacts neurogenesis through increased mTOR signaling. Loss of function of CROCCP2 in human cortical cells and organoids leads to increased ciliogenesis, decreased mTOR signaling, and impaired basal progenitor amplification. These data identify CROCCP2 as a human-specific modifier of cortical neurogenesis that acts through modulation of ciliary dynamics and mTOR signaling.

Keywords: CROCC; CROCCP2; cerebral cortex; cilia; evolution; human brain development; mTOR; neurogenesis; rootlet; rootletin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cilia* / metabolism
  • Cytoskeleton / metabolism
  • Humans
  • Mice
  • Neurogenesis
  • Signal Transduction*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • mTOR protein, mouse